Skip to content

KPD PHARMA

Active
Private limited company (pre-2019)founded 201313 yrs activeAugust De Boeckstraat 45, 1140 Evere, BelgiumKBO/BCE: BE 0537.774.136
Summary

The computed 12-month bankruptcy probability of KPD PHARMA is 17.4% (high). For KPD PHARMA, at least two filing cycles of the annual accounts are missing. The 2021 annual accounts show negative equity (-€2,790) and a net result of -€18,602. Equity is shrinking by ~62.7% per year across the filed fiscal years. The company has been active since 2013 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).

Checked score

No current score
Figures too old
The available figures for FY 2021 are too old to assess current financial health.
Bankruptcy probability: High
Filing: At least two filing cycles are missing
Axes, FY 2021 · tick = 2020
Profitability0=
Solvency20▼-25
Growth58=
Track record92
Bankruptcy probability, 12 months
17.4% High
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Nine signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2021
Solvency, return and age of the figures
Solvency
-4.6%
Return on assets
-30.5%
Age of the figures
57 mo
raises risk · Recent warning signals
The last 24 months brought warning signals in the Staatsblad or the KBO, and those often pile up before a bankruptcy.
Belgian State Gazette
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Ex-officio strike-off
The KBO struck this company off ex officio, which points to unmet obligations and often precedes a bankruptcy.
KBO publications
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 13 years 0 20 y
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2022, 4 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 9 filings
Position against the passed deadline
31-12-2022 close31-07-2023 deadline28-09-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2021 was due by 31-07-2022 and was filed on 29-06-2022, 32 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
not filed
2021
32 d early
2020
11 d late
2019
31 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 3 accounts on average 17 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

raises risk · Administrative warnings in the KBO publications
1 publication by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or its withdrawal.
KBO publications
Publications
Late accounts filing

History

KPD PHARMA was incorporated on 22 August 2013.1 Total assets fell from EUR 191,007 in 2018 to EUR 61,015 in 2021.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2021

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2021, abbreviated schema

Equity
-€2,790
2020 · €15,812
Total assets
€61,015▼ 23.4%
2020 · €79,617
Net result
-€18,602▼ 4.2%
2020 · -€17,847
Working capital
-€20,047▼ 6.9%
2020 · -€18,746
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line2018201920202021
Operating result-€51,363-€3,647-€17,827-€18,572▼ 4.2%
Net result-€56,367-€3,447-€17,847-€18,602▼ 4.2%
Equity€30,211-€33,659▲ 11.4%€15,812▼ 53.0%-€2,790
Total assets€191,007-€133,763▼ 30.0%€79,617▼ 40.5%€61,015▼ 23.4%
Debt€160,796-€100,105▼ 37.7%€63,805▼ 36.3%€63,805=
Working capital-€38,946--€18,199▲ 53.3%-€18,746▼ 3.0%-€20,047▼ 6.9%
Staff (FTE)1.4-
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
-€60,000-€40,000-€20,000€0Operating result 2018: -€51,363-€51,363Net result 2018: -€56,367-€56,367Operating result 2019: €3,647€3,647Net result 2019: €3,447€3,447Operating result 2020: -€17,827-€17,827Net result 2020: -€17,847-€17,847Operating result 2021: -€18,572-€18,572Net result 2021: -€18,602-€18,6022018201920202021-€20,000-€10,000€0Operating result 2019: €3,647€3,650Net result 2019: €3,447€3,450Operating result 2020: -€17,827-€17,800Net result 2020: -€17,847-€17,800Operating result 2021: -€18,572-€18,600Net result 2021: -€18,602-€18,600201920202021
The operating result stays negative: a loss of €18,572 in 2021 against €17,827 in 2020; the loss grows.
Balance-sheet composition
2021 in colour, 2020 as the grey bar beneath
Assets €61,015
Fixed assets €17,257 ▼ 50.1%
Current assets €43,758 ▼ 2.9%
Key figures and ratios
2021 value · change against 2020
EBITDA
-€1,272▼
2020 · -€527
Cash flow
-€1,302▼
2020 · -€547
Solvency
-4.6%▼
2020 · 19.9%
Current ratio
0.69▼
2020 · 0.71
Debt to equity
-22.87
ROA
-30.5%▼
2020 · -22.4%
Interest coverage
-42.39
Debt ≤ 1 year
€63,805=
2020 · €63,805
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2021 against 2020 · 32 lines
Balance sheet Code20202021
Assets
Total assets20/58€79,617€61,015▼
Fixed assets21/28€34,557€17,257▼
Intangible fixed assets21€34,557€17,257▼
Current assets29/58€45,059€43,758▼
Amounts receivable within one year40/41€351€351=
Other amounts receivable41-€351
Cash at bank and in hand54/58€44,708€43,407▼
Equity and liabilities
Total equity and liabilities10/49€79,617€61,015▼
Equity10/15€15,812-€2,790▼
Contributions10/11-€51,848
Reserves13€456,196€440,626▼
Non-distributable reserves130/1-€3,831
Reserves not available under the articles1311-€3,831
Tax-exempt reserves132-€296,496
Distributable reserves133-€140,299
Profit (loss) carried forward14-€492,233-€495,265▼
Amounts payable17/49€63,805€63,805=
Amounts payable within one year42/48€63,805€63,805=
Taxes, remuneration and social security45-€105
Taxes450/3-€105
Other amounts payable47/48-€63,700
Income statement Code20202021
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17,300€17,300=
Gross operating margin9900€36-€1,272▼
Operating profit (loss)9901-€17,827-€18,572▼
Financial charges65/66B-€30
Recurring financial charges65€20€30▲
Profit (loss) for the period before taxes9903-€17,847-€18,602▼
Profit (loss) for the period9904-€17,847-€18,602▼
Transfer from tax-exempt reserves789-€15,570
Profit (loss) for the period to be appropriated9905-€2,277-€3,032▼
Appropriation of the result
Profit (loss) to be appropriated9906--€495,265
Profit (loss) brought forward from the previous period14P--€492,233

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2018201920202021Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17,300€17,300€17,300€17,300=
Gross operating margin9900€84,620€34,155€36-€1,272▼ 3,682%
Operating profit (loss)9901-€51,363€3,647-€17,827-€18,572▼ 4.2%
Recurring financial income75€408----
Financial charges65/66B---€30-
Recurring financial charges65€1,611€95€20€30▲ 50.0%
Profit (loss) for the period before taxes9903-€52,567€3,552-€17,847-€18,602▼ 4.2%
Income taxes67/77€3,801€105---
Profit (loss) for the period9904-€56,367€3,447-€17,847-€18,602▼ 4.2%
Transfer from tax-exempt reserves789---€15,570-
Profit (loss) for the period to be appropriated9905-€19,140€19,017-€2,277-€3,032▼ 33.2%
Line2018201920202021Change
Assets
Total assets20/58€191,007€133,763€79,617€61,015▼ 23.4%
Fixed assets21/28€69,157€51,857€34,557€17,257▼ 50.1%
Intangible fixed assets21€69,157€51,857€34,557€17,257▼ 50.1%
Current assets29/58€121,850€81,906€45,059€43,758▼ 2.9%
Amounts receivable within one year40/41€22,960€30,351€351€351=
Other amounts receivable41---€351-
Cash at bank and in hand54/58€98,890€51,555€44,708€43,407▼ 2.9%
Equity and liabilities
Total equity and liabilities10/49€191,007€133,763€79,617€61,015▼ 23.4%
Equity10/15€30,211€33,659€15,812-€2,790▼ 118%
Contributions10/11€51,848€51,848-€51,848-
Reserves13€486,385€471,766€456,196€440,626▼ 3.4%
Non-distributable reserves130/1---€3,831-
Reserves not available under the articles1311---€3,831-
Tax-exempt reserves132---€296,496-
Distributable reserves133---€140,299-
Profit (loss) carried forward14-€508,023-€489,956-€492,233-€495,265▼ 0.6%
Amounts payable17/49€160,796€100,105€63,805€63,805=
Amounts payable within one year42/48€160,796€100,105€63,805€63,805=
Trade debts44€59,384----
Taxes, remuneration and social security45---€105-
Taxes450/3---€105-
Other amounts payable47/48---€63,700-
Line2018201920202021Change
Profit (loss) for the period9904-€56,367€3,447-€17,847-€18,602▼ 4.2%
+ Depreciation and write-downs630€17,300€17,300€17,300€17,300=
Operating cash flow (approximation)-€39,067€20,747-€547-€1,302▼ 138%
Investment in fixed assets (approximation)-€0€0€0-
Change in cash--€47,335-€6,847-€1,302▲ 81.0%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
28-08
KBO administration Late accounts filing
event 18-08-2026
2022
29-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
11-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 11 days late
2020
30-06
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial Back to profitnet €3,447
Net result €3,447 after one loss-making year.
16-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
06-09
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 37 days late
2017
19-05
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
31-05
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
2015
09-06
NBB filing Annual accounts filed
fiscal year 2014 · abbreviated schema
2014
11-06
NBB filing Annual accounts filed
fiscal year 2013 · abbreviated schema
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts

We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Evere · 1 establishment unit since 2013
seat establishment The establishment unit on the map
Ground area
614 m²
Building footprint
305 m²
Volume, LiDAR
2,184 m³
2 parcels, Brussels · tallest building 13.6 m, ±3 floors. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
KPD PHARMA
Jules Destréestraat 78, 1030 SchaarbeekRetail sale of pharmaceutical products
since 20132.221.879.129
2 parcels
Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21372D0248/00P004 Brussels 491 m² 1 · 235 m² 13.6 m · 2 fl.
21903B0020/00C002 Brussels 123 m² 1 · 70 m² 10.8 m · 3 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner

Chain of control

  1. WIM DE MAREZ 99.75%
  2. Apotheek Hildegard 100%
  3. KPD PHARMA

Highest known parent: WIM DE MAREZ. The sources do not say who stands above it.

Owners 1

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Identification & contact

Identification
Legal formPrivate limited company (pre-2019)
Founded22-08-2013
Fiscal year end31-12
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

If you follow this company, Checked tells you the day it appears in the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.